Anticancer Drugs Market Size & Share to Surpass USD 303.1 billion by 2031 | Analysis by Transparency Market Research, Inc.
14 déc. 2023 04h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global anticancer drugs market was projected to attain US$ 140.2 billion in 2022. It is...
Kura Oncology’s Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society’s Pediatric Acute Leukemia (PedAL) Master Clinical Trial
08 déc. 2023 07h30 HE
|
Kura Oncology, Inc.
SAN DIEGO, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Gift of Life Marrow Registry Drives Awareness, Celebrates Lives Saved at NHL Hockey Fights Cancer Night
01 déc. 2023 10h22 HE
|
Gift of Life Marrow Registry
Gift of Life Marrow Registry teamed up with the Florida Panthers and Nashville Predators for NHL’s Hockey Fights Cancer initiative.
Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference
09 nov. 2023 16h01 HE
|
Vor Biopharma
Primary neutrophil engraftment of trem-cel achieved in all seven patients treated to dateAll three patients receiving multiple Mylotarg™ doses exhibited hematologic protection, further validating Vor...
Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update
07 nov. 2023 16h05 HE
|
Vor Biopharma
Next trem-cel (VOR33) clinical data update expected by Relapse After Transplant and Cellular Therapy (HSCT2) Conference Nov 10-11Three oral abstracts and two poster presentations accepted at ASH 2023...
Vor Bio to Participate in Upcoming Investor Conferences
03 nov. 2023 08h00 HE
|
Vor Biopharma
CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming...
Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform
02 nov. 2023 09h01 HE
|
Vor Biopharma
Three oral and two poster presentations accepted by ASHCompany to host call featuring Sarah K. Tasian, MD, Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine and...
Global Targeted Therapeutics Market Size to Reach USD 214.31 Billion in 2032 | Emergen Research
16 oct. 2023 09h09 HE
|
Emergen Research
Vancouver, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Current Market Scenario (Market estimates) The global Targeted Therapeutics Market size was USD 93.75 Billion in 2020. Increasing prevalence of cancer,...
Acute Lymphoblastic Leukemia Market to Surpass USD 4.5 billion with CAGR 7.6% by 2031,TMR Report
05 oct. 2023 07h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The acute lymphoblastic leukemia market was estimated to have acquired US$ 2.2 billion in...
Leukapheresis Market Research Report 2023 - Global Opportunity/Analysis to 2028
25 sept. 2023 10h33 HE
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma),...